Evidence map›Paper›PMID 19490417›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2009

The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis.

Michael W Milks, James G Cripps, Heping Lin, Jing Wang, Richard T Robinson, Jennifer L Sargent, Michael L Whitfield, James D Gorham

Open access · greenAbstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Drug-induced autoimmune-like hepatitis.Digestive diseases and sciences · 2011
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Michael W MilksDepartment of Pathology, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center,One Medical Center Drive, Lebanon, NH 03756, USA.
James G Cripps
Heping Lin
Jing Wang
Richard T Robinson
Jennifer L Sargent
Michael L Whitfield
James D Gorham
Dartmouth–Hitchcock Medical Center · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
VASCULAR LEUKOCYTES: BASIC IMMUNOBIOLOGY AND FUNCTIONAL PLASTICITYP20RR016437 · NCRR · DARTMOUTH COLLEGE · PI ENELOW, RICHARD I · 2001 to 2010
$24.3M
IMMUNOBIOLOGY OF MYELOID AND LYMPHOID CELLST32AI007363 · NIAID · DARTMOUTH COLLEGE · PI Claudia V Jakubzick · 1990 to 2026
$9.5M
Chemokines in Autoimmune HepatitisR01AI078195 · NIAID · DARTMOUTH COLLEGE · PI GORHAM, JAMES D. · 2009 to 2013
$2.2M
AUTOIMMUNITY &CONNECTIVE TISSUE BIOLOGY TRAININGT32AR007576 · NIAMS · DARTMOUTH COLLEGE · PI RIGBY, WILLIAM FREDERICK CARSON · 1994 to 2008
$1.7M
Mechanisms of liver disease in a mouse model of AIHR01AI053056 · NIAID · DARTMOUTH COLLEGE · PI GORHAM, JAMES D. · 2003 to 2006
$1.4M
Genetic Linkage Analysis of Liver Disease in MiceR21DK073904 · NIDDK · DARTMOUTH COLLEGE · PI GORHAM, JAMES D. · 2005 to 2006
$434k
NCI NIH HHS P30 CA023108NCRR NIH HHS P20 RR016437NCRR NIH HHS P20RR16437NIAID NIH HHS AI053056NIAID NIH HHS AI078195NIAID NIH HHS R01 AI053056NIAID NIH HHS R01 AI078195NIAID NIH HHS T32 AI007363NIAID NIH HHS T32AI07363NIAMS NIH HHS T32 AR007576NIAMS NIH HHS T32AR07576NIDDK NIH HHS DK073904NIDDK NIH HHS R21 DK073904
6 · The paper itself

Abstract

BACKGROUND/

aimsBALB/c mice with a homozygous deficiency in the Tgfb1 gene are a model of fulminant autoimmune hepatitis (AIH), spontaneously and rapidly developing Th1-mediated IFN-gamma-dependent necroinflammatory liver disease. We sought to understand the molecular basis for fulminant Th1 liver disease and the specific role of the Ifng gene.

methodsGlobal gene expression in livers from BALB/c Tgfb1(-/-) mice with and without an intact Ifng gene was assessed by microarray analysis. Expression patterns were confirmed by quantitative reverse transcriptase-polymerase chain reaction. Gene ontology clustering analysis was performed to identify altered pathways. The contributions of Ifng to altered expression pathways were quantified.

resultsOver 100 genes were strongly (>10-fold) upregulated, most encoding proteins involved in immune function/response. Chemokines were the most prominently upregulated group, with eight chemokine genes upregulated >10-fold. Ifng was necessary for the upregulation of CXC chemokines gene, but not of CC chemokine genes. By quantitative analysis, Ifng's role in liver gene upregulation varied greatly among overexpressed genes.

conclusionsGene expression changes indicate a particularly important and heretofore unappreciated role for chemokines in fulminant AIH. Ifng has an important role in expression of some but not all genes. Ifng is dichotomous in the regulation of distinct chemokine subfamilies: specifically, Ifng is critical for overexpression of specific CXCL genes but dispensable for overexpression of specific CCL genes. These results provide a clearer understanding of the role of Ifng in the molecular basis of necroinflammatory liver disease.

Indexed as

AnimalsChemokinesDisease Models, AnimalGene Expression ProfilingGene Expression RegulationHepatitis, AutoimmuneInterferon-gammaLiverMiceMice, Inbred BALB CReverse Transcriptase Polymerase Chain ReactionTransforming Growth Factor beta1ChemokinesInterferon-gammaTransforming Growth Factor beta1

Identifiers

PMID19490417
PMCPMC3038248
OpenAlexW1975868034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.